Up 2,146% in 1 year, Vulcan Energy (ASX:VUL) share price falls on dual listing news
Listing on multiple exchanges can increase a company’s profile and liquidity.The post Up 2,146% in 1 year, Vulcan Energy…
West Gate Tunnel budget blows out by $3.3 billion, Transurban reveals – The Age
Tolling giant Transurban has confirmed to investors the $6.7 billion West Gate Tunnel project has blown out by $3.3…
Are you a ‘Catch and Release’ investor?
The ‘value’ of ‘growth’
The post Are you a ‘Catch and Release’ investor? appeared first on The Motley Fool Australia.
Police launch investigation into Alibaba sexual assault allegations – The Guardian
Chinese e-commerce company says it is cooperating with the investigation
11 new cases, Bunnings jab pop-up opens – Herald Sun
• This coronavirus article is unlocked and free to read in the interest of community health and safety.
Money Fleeing China Stocks May Overlook Pricey India, UBS Says
(Bloomberg) — Investors pulling out of China due to the recent regulatory crackdown may overlook India, where stocks are…
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved…
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
HANGZHOU and SHAOXING, China, Aug. 8, 2021 /PRNewswire/ — Ascletis Pharma Inc. (HKEX code: 1672) today announces that China…
Why This Gold Stock Rallied 10% in July When Others Fell
Despite several analyst downgrades, interest in Franco-Nevada shares picked up ahead of its earnings release.
Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China
CAMBRIDGE, Mass. & HONG KONG & SHANGHAI & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Epizyme, Inc. (“Epizyme”) (Nasdaq: EPZM), a fully…
recent post
-
Dec 15 2025 -
Dec 15 2025
-
Dec 15 2025
-
Dec 15 2025
-
Dec 15 2025
